Menu Back toSession-2-Quality-Tolerance-Limits-QTLs

7th DIA Clinical Operations and Monitoring Workshop in Japan

All prices are exclusive of 10% Japanese consumption tax

Session 2 - Quality Tolerance Limits (QTLs)

Session Chair(s)

Satoshi  Saeki, MSc

Satoshi Saeki, MSc

  • Executive Director, Head of Japn Operational Excellence, Medical Affairs, Japan
  • Astellas Pharma Inc., Japan

Speaker(s)

Hideki  Suganami, PhD

Session 2 - Presentation 1

Hideki Suganami, PhD

  • Director, Clinical Data Science Dept.
  • Kowa Company, Ltd., Japan
Masato  Kobayashi

Session 2 - Presentation 2

Masato Kobayashi

  • Asc Dir, Clinical Quality Assurance, Clinical & Research Quality Assurance
  • Astellas Pharma Inc., Japan

Contact us


Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574